MedPath

TEVA-HALOPERIDOL

TEVA-HALOPERIDOL

Approved
DIN Number

00363669

Drug Class

Human

Market Date

Dec 31, 1986

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00363669
AIG Number0101774004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AD01 HALOPERIDOL
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:16.08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

HALOPERIDOLActive
Strength: 2 MG
Monograph: HALOPERIDOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.